Linked from

The 63 pages that link to Chronic kidney disease, each with the reason it gives.

• HypertensionRelated: Hypertension can damage kidney vessels, and kidney disease can further raise pressure.

• AtherosclerosisRelated: Atherosclerotic disease in renal arteries can reduce kidney perfusion and contribute to kidney injury.

• Acute kidney injuryCompared with: Acute injury develops rapidly, but incomplete recovery can leave chronic kidney disease.

• Blood pressureRelated: Kidney damage can both result from and worsen abnormal blood pressure.

• Foodborne illnessRelated: Severe foodborne infections and their complications can leave lasting kidney damage.

• HyperkalemiaRelated: Reduced kidney capacity can limit potassium excretion, especially as disease advances.

• KidneyRelated: Progressive loss of function can impair filtration and fluid regulation.

• HemodialysisRelated: Progressive disease can make ongoing hemodialysis necessary.

• ErythropoietinRelated: Damaged kidneys may produce too little erythropoietin, contributing to anemia.

• Glomerular filtration rateRelated: GFR helps define and stage chronic kidney disease when reduced over time.

• ACE inhibitorRelated: ACE inhibitors can reduce albumin leakage and slow progression in some patients.

• Glomerular filtrationRelated: Progressive loss of functioning glomeruli can reduce filtration capacity.

• NephrotoxicityCompared with: It contrasts lasting kidney impairment with acute injury after a toxic exposure.

• Renal impairmentNarrower topic: Persistent renal impairment is classified within this broader diagnostic framework.

• Diabetic nephropathyNarrower topic: Diabetic nephropathy is one cause of this broader condition.

• Electrolyte imbalanceRelated: Reduced kidney function can impair potassium, phosphate, and acid-base regulation.

• ProteinuriaNarrower topic: Persistent albuminuria can establish kidney damage even when filtration remains preserved.

• AllopurinolRelated: Kidney function influences oxypurinol clearance and allopurinol dosing decisions.

• UrineRelated: Reduced kidney function can alter urine production and composition.

• ErythropoiesisRelated: Reduced renal erythropoietin production commonly contributes to anemia in this disease.

• Nephrotic syndromeRelated: Some underlying glomerular diseases progress to lasting loss of kidney function.

• Renal replacement therapyNarrower topic: Progressive chronic disease can lead to kidney failure requiring long-term replacement.

• Renal tubular acidosisCompared with: Unlike classic renal tubular acidosis, advanced disease can cause acidosis as filtration declines.

• GLP-1 receptor agonistRelated: Certain agents can reduce kidney-related risks in people with type 2 diabetes and chronic kidney disease.

• Granulomatosis with polyangiitisRelated: Severe or recurrent glomerulonephritis can leave lasting renal damage despite remission.

• HypocalcemiaRelated: Impaired phosphate excretion and altered vitamin D activation can contribute to low calcium.

• NephrolithiasisRelated: Repeated obstruction, infection, or associated disorders may contribute to kidney damage.

• RicketsRelated: Kidney dysfunction can disrupt vitamin D activation and mineral balance, causing renal rickets.

• Urinary systemRelated: It illustrates the long-term consequences of impaired urinary filtration.

• Kidney stoneRelated: Repeated obstruction or associated kidney damage can contribute to lasting functional loss.

• Primary aldosteronismRelated: The disorder is associated with kidney damage, making detection and targeted treatment clinically consequential.

• Angiotensin IIRelated: Angiotensin II can increase glomerular pressure and contribute to progressive kidney injury.

• CreatinineRelated: Repeated creatinine-based estimates help detect and stage reduced kidney function.

• Polycystic kidney diseaseNarrower topic: Progressive cyst-related tissue damage can lead to this broader condition.

• Alport syndromeNarrower topic: Progressive kidney disease is the principal long-term health consequence of Alport syndrome.

• GlomerulonephritisNarrower topic: Ongoing glomerular damage can leave lasting loss of kidney function.

• NephrocalcinosisRelated: Extensive or persistent nephrocalcinosis can be associated with declining kidney function.

• CaptoprilNarrower topic: Captopril may protect some kidneys, though reduced filtration or high potassium can limit its use.

• Glycated hemoglobinRelated: Anemia, altered red-cell survival, and treatment can reduce measurement accuracy.

• HomocysteineRelated: Reduced kidney function can elevate homocysteine, making it difficult to interpret as an independent risk factor.

• NephrologyRelated: Nephrologists assess its causes, monitor progression, and manage complications.

• Post-streptococcal glomerulonephritisRelated: Persistent impairment is uncommon, but can follow severe disease, especially in adults.

• CystinuriaRelated: Severe recurrent obstruction, infection, or procedures can contribute to lasting kidney damage.

• Fanconi syndromeRelated: Certain inherited and acquired causes can lead to progressive renal impairment.

• Paroxysmal nocturnal hemoglobinuriaRelated: Repeated hemoglobin exposure and other effects of PNH can damage the kidneys.

• UremiaNarrower topic: Progressive chronic kidney disease is a common route to the kidney failure underlying uremia.

• Kidney failureBroader topic: This is the long-term disease pathway that can progress to kidney failure.

• Kidney stone diseaseRelated: Repeated obstruction, infection, or certain stone disorders can damage kidney function over time.

• LisinoprilRelated: Lisinopril may protect kidneys in proteinuric disease, though kidney function and potassium require monitoring.

• LosartanRelated: Losartan may reduce albuminuria and protect kidney function in selected patients.